2025³â 06¿ù 20ÀÏ ±Ý¿äÀÏ
 
 
  ÇöÀçÀ§Ä¡ > ´º½ºÁö´åÄÄ > Science & Technology

·£¼¶¿þ¾îºÎÅÍ µÅÁöµµ»ì±îÁö... ³ë·ÃÇØÁø »ç±âÇà°¢

 

Á¤Ä¡

 

°æÁ¦

 

»çȸ

 

»ýȰ

 

¹®È­

 

±¹Á¦

 

°úÇбâ¼ú

 

¿¬¿¹

 

½ºÆ÷Ã÷

 

ÀÚµ¿Â÷

 

ºÎµ¿»ê

 

°æ¿µ

 

¿µ¾÷

 

¹Ìµð¾î

 

½Å»óǰ

 

±³À°

 

ÇÐȸ

 

½Å°£

 

°øÁö»çÇ×

 

Ä®·³

 

Ä·ÆäÀÎ
Çѻ츲 ¡®¿ì¸®´Â ÇѽҸ²¡¯ ½Ò ¼Òºñ Ä·ÆäÀÎ ½Ã...
1000¸¸¿øÂ¥¸® Àΰø¿Í¿ì, °Ç°­º¸Çè Áö¿ø ¡®Æò...
- - - - - - -
 

Samsung Extends Leadership in 5G Patents

The company recognized as industry leader in share of 5G patent ownership
´º½ºÀÏÀÚ: 2021-03-10

SEOUL, Korea – March 10, 2021 – Samsung Electronics Co., Ltd. today announced that it has ranked first in 5G Standard Essential Patent shares according to a patent essentiality study conducted by IPlytics, a Berlin-based market intelligence firm comprised of economists, scientists and engineers. The findings were published in IPlytics’ recent report: “Who is leading the 5G patent race? A patent landscape analysis on declared SEPs and standards contributions.”
 
Samsung also ranked second in two other categories: share of 5G granted[3] and active patent[4] families[5], and share of 5G granted and active patent families with at least one of them granted by the EPO (European Patent Office) or USPTO (United States Patent and Trademark Office).
 
Last year, Samsung also led in 5G patents as a result of its research and development of 5G standards and technologies.
Samsung has pioneered the successful delivery of 5G end-to-end solutions including chipsets, radios, and core. Through ongoing research and development, Samsung drives the industry to advance 5G networks with its market-leading product portfolio from fully virtualized RAN and Core to private network solutions and AI-powered automation tools. The company is currently providing connectivity to hundreds of millions of users around the world.
 



 Àüü´º½º¸ñ·ÏÀ¸·Î

Smart Factory: Ushering in a New Era of Manufacturing Open share list
Yokogawa Announces Release of Next-Generation of the CENTUM VP Integrated Production Control System
Faraday Unveils FlashKit¢â-22RRAM: An eNVM-Based SoC Development Platform for IoT
Innoviva Specialty Therapeutics Gains FDA Acceptance for Zoliflodacin, a First-in-Class Oral Antibiotic for Adult Gonorrhea Treatment
HistoSonics and Cambridge University Unveil Europe¡¯s First Edison¢â Histotripsy System Powered by Li Ka Shing Foundation Gift
Fujirebio Announces Strategic Collaboration with Stanford Medicine to Advance Infectious Disease Research
IQM¡¯s State of Quantum 2025: Quantum Industry Must Solve Talent Shortage and Software Platforms, Not Just Qubits

 

Novotech Showcased in Global Biotech Series for Innovation in Hepatiti...
ImmunAbs Announces FDA Phase 2 IND Approval of IM-101, a Novel Complem...
Rimini Street Announces the Extension of Support for All SAP ECC 6.0 a...
HistoSonics Completes Enrollment in #HOPE4KIDNEY Trial Evaluating Non-...
Tier-1 MVNO Selects Tecnotree¡¯s AI-Native BSS for Multi-Country Trans...
New LG Smart Monitor Swing Boosts Productivity with Flexible Stand and...
LambdaTest Integrates with Assembla to Streamline Bug Tracking for Dev...

 


°øÁö»çÇ×
´º½ºÁö ÇÑÀÚ Ç¥±â¿¡ ´ë¸¸½Ä À½Â÷ Ç¥±â '纽ÞÙó¢ ´Ï¿ì½ÃÁö' º´±â
º£³×ÇÁ·Ò º£³×ÀÎÅõ Áß¹® Ç¥±â 宝Ò¬ÜØÙÌ 宝Ò¬ì×öõ(ÜÄÒ¬ÜØÙÌ ÜÄ...
¹Ìµð¾î¾Æ¿ì¾î Mediaour ØÚ体ä²们 ØÚô÷ä²Ùú MO ¿¥¿À ØÚä² ØÚä²
¾Ë¸®¿ìºê Alliuv ä¹备: ä¹联êó备, ¾Ë¶ã Althle ä¹÷åìÌ
¾Ë¸®¾Ë Allial Áß¹® Ç¥±â ä¹××尔 ä¹××ì³
´ºÆÛ½ºÆ® New1st Áß¹® Ç¥±â 纽ììãæ(¹øÃ¼ Òïììãæ), N1 纽1
¿£ÄÚ½º¸ð½º : À̾¾ 'EnCosmos : EC' Áß¹® Ç¥±â ì¤ñµ
¾ÆÀ̵ð¾î·Ð Idearon Áß¹® Ç¥±â ì¤îè论 ì¤îèÖå
¹ÙÀÌ¿ÀÀÌ´Ï Bioini Áß¹® Ç¥±â ù±药研 ù±å·æÚ
¿À½ºÇÁ·Ò Ausfrom 奥ÞÙÜØÙÌ, À£ÇÁ·Ò Welfrom 卫ÜØÙÌ
¿¡³ÊÇÁ·Ò Enerfrom 额ÒöÜØÙÌ ¿¡³ÊÀ¯ºñ Eneruv 额Òöêó备
¾ËÇÁ·Ò Alfrom Áß¹® Ç¥±â ä¹尔ÜØÙÌ ä¹ì³ÜØÙÌ

 

ȸ»ç¼Ò°³ | ÀÎÀçä¿ë | ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸Ãë±Þ¹æÄ§ | û¼Ò³âº¸È£Á¤Ã¥ | Ã¥ÀÓÇѰè¿Í ¹ýÀû°íÁö | À̸ÞÀÏÁÖ¼Ò¹«´Ü¼öÁý°ÅºÎ | °í°´¼¾ÅÍ

±â»çÁ¦º¸ À̸ÞÀÏ news@newsji.com, ÀüÈ­ 050 2222 0002, ÆÑ½º 050 2222 0111, ÁÖ¼Ò : ¼­¿ï ±¸·Î±¸ °¡¸¶»ê·Î 27±æ 60 1-37È£

ÀÎÅͳݴº½º¼­ºñ½º»ç¾÷µî·Ï : ¼­¿ï ÀÚ00447, µî·ÏÀÏÀÚ : 2013.12.23., ´º½º¹è¿­ ¹× û¼Ò³âº¸È£ÀÇ Ã¥ÀÓ : ´ëÇ¥ CEO

Copyright ¨Ï All rights reserved..